Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

Cantuti-Castelvetri, Ludovico, Ojha, Ravi, Pedro, Liliana D., Djannatian, Minou, Franz, Jonas, Kuivanen, Suvi, van der Meer, Franziska, Kallio, Katri +21 more·2020·Science
DOI 10.1126/science.abd2985

Cited by (1,003)

Items 601–700 of 1,003

  1. Multiscale interactome analysis coupled with off-target drug predictions reveals drug repurposing candidates for human coronavirus disease
    Michael G. Sugiyama, Haotian Cui, Dar’ya S. Redka, Mehran Karimzadeh, Edurne Rujas, Hassaan Maan, Sikander Hayat, Kyle Cheung, Rahul Misra, Joseph B. McPhee et al. · 2021 · Scientific Reports
  2. Solasonine Induces Apoptosis and Inhibits Proliferation of Bladder Cancer Cells by Suppressing NRP1 Expression
    Yang Dong, L. Hao, Zhen-Jun Shi, Kun Fang, Hui Yu, Guang-Hui Zang, T. Fan, Cong-Hui Han · 2022 · Journal of Oncology
  3. Identification of broad anti-coronavirus chemical agents for repurposing against SARS-CoV-2 and variants of concern
    Luca Murer, Romain Volle, Vardan Andriasyan, Anthony Petkidis, Alfonso Gómez-González, Liliane Yang, Nicole Meili, Maarit Suomalainen, Michael Bauer, Daniela Policarpo Sequeira et al. · 2022 · Current Research in Virological Science
  4. In SARS-CoV-2, astrocytes are in it for the long haul
    Shuhan Huang, Gord Fishell · 2022 · Proceedings of the National Academy of Sciences
  5. Neuropilin (NRPs) Related Pathological Conditions and Their Modulators
    Matic Broz, Anja Kolarič, Marko Jukič, Urban Bren · 2022 · International Journal of Molecular Sciences
  6. IgG autoantibodies against ACE2 in SARS‐CoV‐2 infected patients
    Ewelina Hallmann, Dominika Sikora, Barbara Poniedziałek, Karol Szymański, Katarzyna Kondratiuk, Jakub Żurawski, Lidia B. Brydak, Piotr Rzymski · 2022 · Journal of Medical Virology
  7. From Co-Infections to Autoimmune Disease via Hyperactivated Innate Immunity: COVID-19 Autoimmune Coagulopathies, Autoimmune Myocarditis and Multisystem Inflammatory Syndrome in Children
    Robert Scott Root-Bernstein · 2023 · International Journal of Molecular Sciences
  8. COVID ‐19 Induces Neuroinflammation and Suppresses Peroxisomes in the Brain
    Andrej Roczkowsky, Daniel Limonta, J. P. Fernandes, William G. Branton, M Clarke, B.A. Hlavay, Ryan S. Noyce, Jeffrey T. Joseph, Natacha S. Ogando, Sangeeta Das et al. · 2023 · Annals of Neurology
  9. SARS-CoV-2 mouse adaptation selects virulence mutations that cause TNF-driven age-dependent severe disease with human correlates
    Stefanie M. Bader, James P. Cooney, Dylan Sheerin, George Taiaroa, Leigh Harty, Kathryn C. Davidson, Liana Mackiewicz, Merle Dayton, Stephen Wilcox, Lachlan W. Whitehead et al. · 2023 · Proceedings of the National Academy of Sciences
  10. Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID
    A. Satyanarayan Naidu, Chin‐Kun Wang, Pingfan Rao, Fabrizio Mancini, Roger Clemens, Aman Wirakartakusumah, Hui‐Fang Chiu, Chi‐Hua Yen, Sebastiano Porretta, Issac Mathai et al. · 2024 · npj Science of Food
  11. Asialoglycoprotein receptor 1 promotes SARS-CoV-2 infection of human normal hepatocytes
    Xinyi Yang, Xu Zheng, Yuqi Zhu, Xiaying Zhao, Jun Liu, Jiangna Xun, Songhua Yuan, Jun Chen, Hanyu Pan, Jin‐Long Yang et al. · 2024 · Signal Transduction and Targeted Therapy
  12. Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1
    Hisano Yajima, Yuki Anraku, Yu Kaku, Kanako Kimura, Arnon Plianchaisuk, Kaho Okumura, Yoshiko Nakada-Nakura, Yusuke Atarashi, Takuya Hemmi, Daisuke Kuroda et al. · 2024 · Nature Communications
  13. COVID‐19 with and without anosmia or dysgeusia: A case‐control study
    Nishanth Dev, Jhuma Sankar, Nitesh Gupta, Ramesh Chand Meena, Charanjit Singh, D. K. Gupta, Manas Kamal Sen · 2021 · Journal of Medical Virology
  14. Update on Antiviral Strategies Against COVID-19: Unmet Needs and Prospects
    Ching‐Hsuan Liu, Cheng-Hua Lu, Shu Hui Wong, Liang Lin · 2021 · Frontiers in Immunology
  15. Molecular-Level Anatomy of SARS-CoV-2 for the Battle against the COVID-19 Pandemic
    Makoto Komiyama · 2021 · Bulletin of the Chemical Society of Japan
  16. Implications of microscale lung damage for COVID-19 pulmonary ventilation dynamics: A narrative review
    Elizabeth D. Dimbath, Veeranna Maddipati, Jennifer Stahl, Kerry B. Sewell, Zachary J. Domire, Stephanie George, Ali Vahdati · 2021 · Life Sciences
  17. Specific Treatment Exists for SARS-CoV-2 ARDS
    Badar A. Kanwar, Asif Khattak, Jong‐Hoon Lee, Jenny Balentine, R. E. Kast, Sang-Suk Oh, Consolato Sergi, Jong‐Hoon Lee · 2021 · Vaccines
  18. Key Considerations for the Development of Safe and Effective SARS‐CoV‐2 Subunit Vaccine: A Peptide‐Based Vaccine Alternative
    Ahmed O. Shalash, Waleed M. Hussein, Mariusz Skwarczyński, István Tóth · 2021 · Advanced Science
  19. One Health: EAACI Position Paper on coronaviruses at the human‐animal interface, with a specific focus on comparative and zoonotic aspects of SARS‐CoV‐2
    Anna D. J. Korath, Jozef Janda, Eva Untersmayr, Milena Sokołowska, Wojciech Feleszko, Ioana Octavia Agache, Ahmed Adel Seida, Katrin Hartmann, Erika Jensen‐Jarolim, Isabella Pali‐Schöll · 2021 · Allergy
  20. SARS-CoV-2 S glycoprotein binding to multiple host receptors enables cell entry and infection
    Irena Trbojević‐Akmačić, Tea Petrović, Gordan Lauc · 2021 · Glycoconjugate Journal
  21. Neuro-COVID-19: an insidious virus in action
    Jolanta Bratosiewicz‐Wąsik · 2021 · Neurologia i Neurochirurgia Polska
  22. The Future of the COVID-19 Pandemic: How Good (or Bad) Can the SARS-CoV2 Spike Protein Get?
    Matthew A. Nugent · 2022 · Cells
  23. Endothelial Dysfunction in SARS-CoV-2 Infection
    Francesco Nappi, Sanjeet Singh · 2022 · Biomedicines
  24. Conservation and Enhanced Binding of SARS-CoV-2 Omicron Spike Protein to Coreceptor Neuropilin-1 Predicted by Docking Analysis
    Piyush Baindara, Roy Dinata, Santi M. Mandal, Adam G. Schrum · 2022 · Infectious Disease Reports
  25. A Functional Interaction Between Y674-R685 Region of the SARS-CoV-2 Spike Protein and the Human α7 Nicotinic Receptor
    Juan Facundo Chrestia, A. Sofia F. Oliveira, Adrian John Mulholland, Timothy C. Gallagher, Isabel Bermúdez, Cecilia Bouzat · 2022 · Molecular Neurobiology
  26. Lycopene: a therapeutic strategy against coronavirus disease 19 (COVID- 19)
    Banlambhabok Khongthaw, Kanika Dulta, P.K. Chauhan, Vinod Kumar, Joshua O. Ighalo · 2022 · Inflammopharmacology
  27. SARS‐CoV‐2 infection of kidney tissues from severe COVID‐19 patients
    Shawn Radovic, Wen Meng, Luping Chen, Alberto E. Paniz Mondolfi, Clare Bryce, Zachary Grimes, Emilia Mia Sordillo, Carlos Cordon‐Cardo, Haitao Guo, Yufei Huang et al. · 2023 · Journal of Medical Virology
  28. Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants
    Esmaeel Sharifi, Satar Yousefiasl, Maria Trovato, Rossella Sartorius, Yasaman Esmaeili, Hamid Goodarzi, Matineh Ghomi, Ashkan Bigham, Farnaz Dabbagh Moghaddam, Maryam Heidarifard et al. · 2023 · Journal of Nanobiotechnology
  29. Infection with SARS-CoV-2 can cause pancreatic impairment
    Wei Deng, Linlin Bao, Zhiqi Song, Ling Zhang, Pin Yü, Yanfeng Xu, Jue Wang, Wenjie Zhao, Xiuqin Zhang, Yunlin Han et al. · 2024 · Signal Transduction and Targeted Therapy
  30. Disruption of nuclear architecture as a cause of COVID-19 induced anosmia
    Marianna Zazhytska, Albana L. Kodra, Daisy A. Hoagland, John F. Fullard, Hani J. Shayya, Arina D. Omer, Stuart Firestein, Qizhi Gong, Peter Canoll, James E. Goldman et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  31. Membrane lectins enhance SARS-CoV-2 infection and influence the neutralizing activity of different classes of antibodies
    F. Lempp, Leah B. Soriaga, Martin Montiel-Ruiz, F. Benigni, Julia Noack, Young-Jun Park, S. Bianchi, A. Walls, J. Bowen, Jia-Yi Zhou et al. · 2021 · bioRxiv
  32. SARS-CoV-2 Spike Protein Accumulation in the Skull-Meninges-Brain Axis: Potential Implications for Long-Term Neurological Complications in post-COVID-19
    Zhouyi Rong, Hongcheng Mai, Saketh Kapoor, Victor G. Puelles, Jan Czogalla, Julia Schädler, Jessica Vering, Claire Delbridge, Hanno Steinke, Hannah Frenzel et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  33. Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids
    Rahmani, Waleed, Chung, Hyunjae, Sinha, Sarthak, Bui-Marinos, Maxwell P., Arora, Rohit, Jaffer, Arzina, Corcoran, Jennifer A., Biernaskie, Jeff, Chun, Justin · 2022 · iScience
  34. Astrocytes Are a Key Target for Neurotropic Viral Infection
    Maja Potokar, Robert Zorec, Jernej Jorgačevski · 2023 · Cells
  35. The relationship between SARS-CoV-2 infection and type 1 diabetes mellitus
    Cyril Debuysschere, Magloire Pandoua Nekoua, Enagnon Kazali Alidjinou, Didier Hober · 2024 · Nature Reviews Endocrinology
  36. Role of Iron Chelation and Protease Inhibition of Natural Products on COVID-19 Infection
    Giuseppe Carota, Simone Ronsisvalle, Federica Panarello, Daniele Tibullo, Anna Nicolosi, Giovanni Li Volti · 2021 · Journal of Clinical Medicine
  37. Perturbation of semaphorin and VEGF signaling in ACDMPV lungs due to FOXF1 deficiency
    Justyna A. Karolak, Tomasz Gambin, Przemysław Szafrański, Rebecca L. Maywald, Edwina J. Popek, Jason D. Heaney, Paweł Stankiewicz · 2021 · Respiratory Research
  38. Pneumocytes are distinguished by highly elevated expression of the ER stress biomarker GRP78, a co-receptor for SARS-CoV-2, in COVID-19 autopsies
    Andrii Puzyrenko, Elizabeth Rogers Jacobs, Yunguang Sun, Juan Carlos Felix, Yuri M. Sheinin, Linna Ge, Shuping Lai, Qiang Dai, Benjamin N. Gantner, Rahul S. Nanchal et al. · 2021 · Cell Stress and Chaperones
  39. Cell therapy strategies for COVID-19: Current approaches and potential applications
    Mark M. Zaki, Emal Lesha, Khaled Said, Kiavash Kiaee, Lindsey R. Robinson‐McCarthy, Haydy George, Angy Hanna, Evan Appleton, Songlei Liu, Alex H. M. Ng et al. · 2021 · Science Advances
  40. Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?
    Berta Soldevila, Manel Puig‐Domingo, Mónica Marazuela · 2021 · Reviews in Endocrine and Metabolic Disorders
  41. Expression pattern and function of SARS-CoV-2 receptor ACE2
    Rui-Ting Li, Cheng‐Feng Qin · 2021 · Biosafety and Health
  42. Immunohistochemical and qPCR Detection of SARS-CoV-2 in the Human Middle Ear Versus the Nasal Cavity: Case Series
    Arwa Kurabi, Kwang K. Pak, Adam S. DeConde, Allen Frederic Ryan, Carol H. Yan · 2021 · Head and Neck Pathology
  43. Mucus targeting as a plausible approach to improve lung function in COVID-19 patients
    Sarath Sreekumar, Aiswarya Binu, Aswathy R. Devan, Lekshmi R. Nath · 2021 · Medical Hypotheses
  44. Common cardiac medications potently inhibit ACE2 binding to the SARS-CoV-2 Spike, and block virus penetration and infectivity in human lung cells
    H. Caohuy, Ofer Eidelman, Tinghua Chen, Shufeng Liu, Qingfeng Yang, Alakesh Bera, Nathan I. Walton, Tony T. Wang, Harvey B. Pollard · 2021 · Scientific Reports
  45. Neuropilin-1, a myeloid cell-specific protein, is an inhibitor of HIV-1 infectivity
    Shumei Wang, Li Zhao, Xiaowei Zhang, Jingjing Zhang, Hong Shang, Guoxin Liang · 2022 · Proceedings of the National Academy of Sciences
  46. Cellular and molecular atlas of the placenta from a COVID‐19 pregnant woman infected at midgestation highlights the defective impacts on foetal health
    Jingsi Chen, Lili Du, Feiyang Wang, Xuan Shao, Xiaoyi Wang, Wenzhe Yu, Shilei Bi, Dexiong Chen, Xingfei Pan, Shanshan Zeng et al. · 2022 · Cell Proliferation
  47. COVID-19 and One-Carbon Metabolism
    Joanna Perła‐Kaján, Hieronim Jakubowski · 2022 · International Journal of Molecular Sciences
  48. Identification and Analysis of SARS-CoV-2 Alpha Variants in the Largest Taiwan COVID-19 Outbreak in 2021
    Li‐Teh Liu, Jih‐Jin Tsai, Ko Chang, Chun‐Hong Chen, Ping‐Chang Lin, Ching‐Yi Tsai, Yan‐Yi Tsai, Miao‐Chen Hsu, Wan‐Long Chuang, Jer‐Ming Chang et al. · 2022 · Frontiers in Medicine
  49. Anti-Fungal Drug Anidulafungin Inhibits SARS-CoV-2 Spike-Induced Syncytia Formation by Targeting ACE2-Spike Protein Interaction
    Shahzaib Ahamad, Hashim Ali, Ilaria Secco, Mauro Giacca, Dinesh Kumar Gupta · 2022 · Frontiers in Genetics
  50. ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1
    Boris Simonetti, James L. Daly, Lorena Simón‐Gracia, Katja Klein, Saroja K. Weeratunga, Carlos Antón-Plágaro, Allan Tobi, Lorna R. Hodgson, Philip A. Lewis, Kate J. Heesom et al. · 2022 · Proceedings of the National Academy of Sciences
  51. PHEV infection: A promising model of betacoronavirus-associated neurological and olfactory dysfunction
    Junchao Shi, Zi Li, Jing Zhang, Rongyi Xu, Yungang Lan, Jiyu Guan, Rui Gao, Zhenzhen Wang, Huijun Lu, Baofeng Xu et al. · 2022 · PLoS Pathogens
  52. miR-142 Targets TIM-1 in Human Endothelial Cells: Potential Implications for Stroke, COVID-19, Zika, Ebola, Dengue, and Other Viral Infections
    Urna Kansakar, Jessica Gambardella, Fahimeh Varzideh, Roberta Avvisato, Stanislovas S. Jankauskas, Pasquale Mone, Alessandro Matarese, Gaetano Santulli · 2022 · International Journal of Molecular Sciences
  53. Natural and Semi-Synthetic Flavonoid Anti-SARS-CoV-2 Agents for the Treatment of Long COVID-19 Disease and Neurodegenerative Disorders of Cognitive Decline
    James Melrose, Margaret Mary Smith · 2022 · Frontiers in Bioscience-Elite
  54. SARS-CoV-2 Receptors and Their Involvement in Cell Infection
    П. П. Авдонин, Elena Yu. Rybakova, Sergei K. Trufanov, Pavel V. Avdonin · 2023 · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology
  55. From Cell to Symptoms: The Role of SARS-CoV-2 Cytopathic Effects in the Pathogenesis of COVID-19 and Long COVID
    Pablo Gonzalez‐Garcia, Ornella Fiorillo Moreno, Eloína Zarate Peñata, Alejandro Calderón-Villalba, Lisandro Pacheco-Lugo, Antonio J. Acosta-Hoyos, Jose Luis Villarreal Camacho, Roberto Navarro Quiroz, Leonardo C. Pacheco‐Londoño, Gustavo Aroca et al. · 2023 · International Journal of Molecular Sciences
  56. Neuropilin-1 is a novel host factor modulating the entry of hepatitis B virus.
    Haibo Yu, Ji-Hua Ren, Hai-Jun Deng, Lin-Feng Li, Zhenzhen Zhang, Sheng-Tao Cheng, Zu-Feng Guo, A. Huang, Yong-Jun Dang, Kunling Song et al. · 2024 · Journal of Hepatology
  57. Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays
    Jenni M. E. Virtanen, Ruut Uusitalo, Essi M. Korhonen, Kirsi Aaltonen, Teemu Smura, Suvi H. Kuivanen, Sari H. Pakkanen, Sointu Mero, Anu Patjas, Marianna Riekkinen et al. · 2021 · Viruses
  58. LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein
    2023
  59. Targeting the vascular endothelial growth factor A/neuropilin 1 axis for relief of neuropathic pain
    Harrison J. Stratton, Lisa Boinon, Kimberly Gómez, Laurent Martin, Paz Duran, Dongzhi Ran, Yuan Zhou, Shizhen Luo, Samantha Perez‐Miller, Marcel Pátek et al. · 2022 · Pain
  60. Mechanisms of COVID‐19‐associated olfactory dysfunction
    Koping Chang, Thomas D. Zaikos, Nicholas Kilner‐Pontone, Cheng‐Ying Ho · 2024 · Neuropathology and Applied Neurobiology
  61. Does common cold coronavirus infection protect against severe SARS-CoV-2 disease?
    David Kyle Meyerholz, Stanley M. Perlman · 2020 · Journal of Clinical Investigation
  62. Novel Targets of SARS-CoV-2 Spike Protein in Human Fetal Brain Development Suggest Early Pregnancy Vulnerability
    Parul Varma, Zane R. Lybrand, Mariah C. Antopia, Jenny Hsieh · 2021 · Frontiers in Neuroscience
  63. Susceptibility of neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection
    Valéry Bielarz, Kévin Willemart, Noémie Avalosse, Kathleen De Swert, Riselane Lotfi, Noémie Lejeune, Florian Poulain, Noëlle Ninane, Jacques Gilloteaux, Nicolas Albert Gillet et al. · 2021 · Brain Research
  64. Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology
    Saeideh Aghayari Sheikh Neshin, Shima Shahjouei, Eric Koza, Isabel Friedenberg, Faezeh Khodadadi, Mirna Sabra, Firas H. Kobeissy, Saeed Ansari, Georgios K. Tsivgoulis, Jiang Li et al. · 2021 · Frontiers in Cardiovascular Medicine
  65. Molecular Perspectives of SARS-CoV-2: Pathology, Immune Evasion, and Therapeutic Interventions
    Masaud Shah, Hyun Goo Woo · 2021 · Molecules and Cells
  66. Neuropilin-1: A feasible link between liver pathologies and COVID-19
    Aitor Benedicto, Iñigo García-Kamiruaga, Beatriz Arteta · 2021 · World Journal of Gastroenterology
  67. Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells
    Michihito Sasaki, Mai Kishimoto, Yukari Itakura, Koshiro Tabata, Kittiya Intaruck, Kentaro Uemura, Shinsuke Toba, Takao Sanaki, Akihiko Sato, William W. Hall et al. · 2021 · Biochemical and Biophysical Research Communications
  68. SARS-CoV-2 Infection and Pancreatic β Cell Failure
    Keiichiro Mine, Seiho Nagafuchi, Hitoe Mori, Hirokazu Takahashi, Keizo Anzai · 2021 · Biology
  69. SARS-CoV-2 Spike protein is not pro-inflammatory in human primary macrophages: endotoxin contamination and lack of protein glycosylation as possible confounders
    Gloria Cinquegrani, Valentina Spigoni, Nicolas Thomas Iannozzi, Vanessa Parello, Riccardo C. Bonadonna, Alessandra Dei · 2022 · Cell Biology and Toxicology
  70. Coronavirus Disease 2019 and Related Parkinsonism: The Clinical Evidence Thus Far
    Iro Boura, К. Ray Chaudhuri · 2022 · Movement Disorders Clinical Practice
  71. SARS-CoV-2 infects human cardiomyocytes promoted by inflammation and oxidative stress
    Melina Tangos, Heidi Budde, Detmar Kolijn, Marcel Sieme, Saltanat Zhazykbayeva, Mária Lódi, Melissa Herwig, Kamilla Gömöri, Roua Hassoun, Emma Louise Robinson et al. · 2022 · International Journal of Cardiology
  72. Molecular ZIP codes in targeted drug delivery
    Erkki I. Ruoslahti · 2022 · Proceedings of the National Academy of Sciences
  73. The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-κB signaling
    Emmanuel Laplantine, Christine Chable-Bessia, Anne Oudin, Jitendryia Swain, Adèle Soria, Peggy Mérida, Manon Gourdelier, Sarra Mestiri, Indira Besseghe, Erwan Brémaud et al. · 2022 · iScience
  74. 3D Lung Tissue Models for Studies on SARS-CoV-2 Pathophysiology and Therapeutics
    Roberto Plebani, Haiqing Bai, Longlong Si, Jing Li, Chunhe Zhang, Mario Romano · 2022 · International Journal of Molecular Sciences
  75. A pseudovirus-based platform to measure neutralizing antibodies in Mexico using SARS-CoV-2 as proof-of-concept
    José Antonio Cruz-Cárdenas, Michelle Gutiérrez, Alejandra López-Arredondo, Julio Enrique Castañeda‐Delgado, Augusto Rojas‐Martínez, Yukio Nakamura, José Antonio Enciso‐Moreno, Laura A. Palomares, Marion E. G. Brunck · 2022 · Scientific Reports
  76. Neurological complications of COVID-19
    Xingliang Dai, Xinxin Cao, Qian Jiang, B Wu, T Lou, Yueming Shao, Ying Hu, Qin Lan · 2022 · QJM
  77. Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19
    Maria Mancini, Silvia Natoli, Fabrizio Gardoni, Mónica Di Luca, Antonio Pisani · 2023 · International Journal of Molecular Sciences
  78. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada
    Aidan M. Nikiforuk, Kevin S. Kuchinski, David D. W. Twa, Christine D. Lukac, Hind Sbihi, C. Andrew Basham, Christian Steidl, Natalie Prystajecky, Agatha N. Jassem, Mel Krajden et al. · 2021 · EBioMedicine
  79. In silico identification and validation of inhibitors of the interaction between neuropilin receptor 1 and SARS-CoV-2 Spike protein
    Samantha Perez‐Miller, Marcel Pátek, Aubin Moutal, Carly R. Cabel, Curtis A. Thorne, Samuel K. Campos, Rajesh Khanna · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  80. Molecular dynamics simulations and functional studies reveal that hBD-2 binds SARS-CoV-2 spike RBD and blocks viral entry into ACE2 expressing cells
    Liqun Zhang, Santosh K. Ghosh, Shrikanth Chomanahalli Basavarajappa, Jeannine Muller‐Greven, Jackson Penfield, Ann Brewer, Parameswaran Ramakrishnan, Matthias Buck, Aaron Weinberg · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  81. An integrative look at SARS‑CoV‑2 (Review)
    Miguel Angel Ortega, Oscar Fraile‐Μartinez, Cielo García Montero, Sandra García‐Gallego, Lara Sánchez‐Trujillo, Diego Torres‐Carranza, Miguel Ángel Álvarez-Mon, Leonel Pekarek, Natalio García‐Honduvilla, Julia Buján et al. · 2020 · International Journal of Molecular Medicine
  82. Neurological involvement of COVID-19: from neuroinvasion and neuroimmune crosstalk to long-term consequences
    Dian Eurike Septyaningtrias, Rina Susilowati · 2021 · Reviews in the Neurosciences
  83. Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge
    M. Winkler, T. Skirecki, F. Brunkhorst, S. Cajander, J. Cavaillon, R. Ferrer, S. Flohé, A. García-Salido, E. Giamarellos-Bourboulis, M. Girardis et al. · 2021 · EBioMedicine
  84. Effect of clinical isolate or cleavage site mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell–cell fusion
    Chelsea T. Barrett, Hadley E. Neal, Kearstin L. Edmonds, Carole L. Moncman, Rachel Thompson, Jean Mawuena Branttie, Kerri Beth Boggs, Cheng‐Yu Wu, Daisy W. Leung, Rebecca Dutch · 2021 · Journal of Biological Chemistry
  85. Immunometabolic Dysregulation at the Intersection of Obesity and COVID-19
    Collins N. Khwatenge, Marquette Pate, Laura C. Miller, Yongming Sang · 2021 · Frontiers in Immunology
  86. A SARS‐CoV‐2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD‐Independent Mechanism**
    Anton Schmitz, Anna Weber, Mehtap Bayin, Stefan Breuers, Volkmar Fieberg, Michael Famulok, Günter Mayer · 2021 · Angewandte Chemie
  87. Mitoxantrone modulates a heparan sulfate-spike complex to inhibit SARS-CoV-2 infection
    Qi Zhang, Peter Radvák, Juhyung Lee, Yue Xu, Vivian Cao-Dao, Miao Xu, Wei Zheng, Catherine Z. Chen, Hang Xie, Yihong Ye · 2022 · Scientific Reports
  88. Could a Lower Toll-like Receptor (TLR) and NF-κB Activation Due to a Changed Charge Distribution in the Spike Protein Be the Reason for the Lower Pathogenicity of Omicron?
    Ralf Kircheis, Oliver Planz · 2022 · International Journal of Molecular Sciences
  89. A systematic review and meta‐analysis of neuropathic pain associated with coronavirus disease 2019
    Giulia Di Stefano, Pietro Falco, Eleonora Galosi, Giuseppe Di Pietro, Caterina Maria Leone, Andrea Truini · 2022 · European Journal of Pain
  90. Mouse-Adapted SARS-CoV-2 MA10 Strain Displays Differential Pulmonary Tropism and Accelerated Viral Replication, Neurodissemination, and Pulmonary Host Responses in K18-hACE2 Mice
    Côme Thieulent, Wellesley Dittmar, Udeni B. R. Balasuriya, Nicholas A. Crossland, Xue Wen, Jüergen A. Richt, Mariano Carossino · 2023 · mSphere
  91. Human brain organoids to explore SARS‐CoV‐2‐induced effects on the central nervous system
    Philipp Niklas Ostermann, Heiner Schaal · 2023 · Reviews in Medical Virology
  92. Delta (B1.617.2) variant of SARS-CoV-2 induces severe neurotropic patterns in K18-hACE2 mice
    Ju-Hee Yang, Myeon‐Sik Yang, Dae-Min Kim, Bumseok Kim, Dongseob Tark, Sangmin Kang, Gun-Hee Lee · 2023 · Scientific Reports
  93. Coronaviruses Use ACE2 Monomers as Entry‐Receptors
    Patrick Eiring, Teresa Klein, Simone Backes, Marcel Streit, Marvin Jungblut, Sören Doose, Gerti Beliu, Markus Sauer · 2023 · Angewandte Chemie International Edition
  94. Microfluidic Organ-Chips and Stem Cell Models in the Fight Against COVID-19
    Sandro Satta, Sarah J. Rockwood, Kaidong Wang, Shaolei Wang, Maedeh Mozneb, Madelyn Arzt, Tzung K. Hsiai, Arun Sharma · 2023 · Circulation Research
  95. Neuropilins: C-end rule peptides and their association with nociception and COVID-19
    Amie Jobe, Ranjit Vijayan · 2021 · Computational and Structural Biotechnology Journal
  96. Glycosylation in cancer and infection : the role of sialic acid
    Yuecheng Zhang · 2021
  97. Biology and therapeutic potential of human innate lymphoid cells
    Sabrina Bianca Bennstein, Markus Uhrberg · 2021 · FEBS Journal
  98. Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19–Convalescent Donors
    Bernd Jahrsdörfer, Rüdiger M. Groß, Alina Seidel, Lukas Wettstein, Carolin Ludwig, Tatjana Schwarz, Sixten Körper, Markus Rojewski, Ramin Lotfi, Christoph Weinstock et al. · 2021 · The Journal of Immunology
  99. The SARS-CoV-2 Transcriptome and the Dynamics of the S Gene Furin Cleavage Site in Primary Human Airway Epithelia
    Wei Zou, Min Xiong, Siyuan Hao, Elizabeth Yan Zhang, Nathalie Baumlin, Michael D. Kim, Matthias A. Salathe, Ziying Yan, Jianming Qiu · 2021 · mBio
  100. Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19
    Emanuela Ricciotti, Krzysztof Laudański, Garret A. FitzGerald · 2021 · Advances in Biological Regulation